Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.

Pre-exposure prophylaxis clinical trials of a 3-dose regimen of Verorab® followed by a booster dose at 1 year in adults and children achieved an adequate immune response.1 Of those who had a booster ...

In the first-ever efficacy trial of antiretroviral-based pre-exposure prophylaxis, once-daily oral tenofovir significantly reduced the risk for HIV acquisition among men who have sex with men. The use ...

ARLINGTON, Virginia, June 11-- The HIV Medicine Association issued the following statement by Chair W. David Hardy on the U.S. Preventive Services Task Force's final pre-exposure prophylaxis ...

MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (PFE) and Shionogi as shareholders, is pleased to ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

Kenya has taken a major step towards expanding HIV prevention options after the Ministry of Health formally recommended the ...

WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (IVVD), a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced that ...

In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and the ...

HIV medication Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) will be offered free by the end of January, Prime Minister Robert Abela said on Sunday. NGOs and people living ...

The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...